FDASmart concludes ‘2nd Pharmaceutical Anti-Counterfeiting Conference’ in Mumbai

Our News Bureau – Mumbai

FDASmart, a US and India-based pharmaceutical regulatory compliance and management cum pharma consulting/training company recently held its ‘2nd Pharmaceutical Anti-Counterfeiting Conference in Emerging Regions’ conference in Mumbai. The theme for the forum was to acknowledge the serious threat of counterfeits and trace a multi-stake holder look at the progress made in winning the battle against counterfeits. A world-class group of experts from the US came together to drive home not only the problems but present innovative solutions to win the war against counterfeiters who seem to get more sophisticated by the day.

Panel discussion at the end of the session involved some provocative discussion which included the audience comments and feedback Speakers included various stakeholders in the pharma industry.

Samir Vasavada,-Controller – External Manufacturing – Abbott India and Deepak Kallakuri – Product Marketing Manager, Vision Systems Marketing – Cognex Corporations spoke about breakthrough vision and identification technologies. Dr Kiran Marthak from Lambda Therapeutics delivered a speech on how counterfeits affect clinical trials while Henal Vakharia –Partner at Kocchar (law firm) thoroughly covered legal aspects of the counterfeit problems with solution and case studies while CP Shastry – B Pharm, MS, MDP (Marketing Strategies), R Ph – Pharma Synergies. spoke about the multi-stale holder strategies we must assemble to win this war.